These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 3167012)
1. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Eastman A; Schulte N Biochemistry; 1988 Jun; 27(13):4730-4. PubMed ID: 3167012 [TBL] [Abstract][Full Text] [Related]
2. DNA-protein cross-linking in L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II). Olinski R; Briggs RC Mol Biol Rep; 1991 May; 15(2):81-6. PubMed ID: 1749377 [TBL] [Abstract][Full Text] [Related]
3. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Strandberg MC; Bresnick E; Eastman A Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396 [TBL] [Abstract][Full Text] [Related]
4. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. Sheibani N; Jennerwein MM; Eastman A Biochemistry; 1989 Apr; 28(7):3120-4. PubMed ID: 2742829 [TBL] [Abstract][Full Text] [Related]
5. The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA. Blommaert FA; Floot BG; van Dijk-Knijnenburg HC; Berends F; Baan RA; Schornagel JH; den Engelse L; Fichtinger-Schepman AM Chem Biol Interact; 1998 Jan; 108(3):209-25. PubMed ID: 9528691 [TBL] [Abstract][Full Text] [Related]
6. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973 [TBL] [Abstract][Full Text] [Related]
7. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266 [TBL] [Abstract][Full Text] [Related]
8. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells. Fram RJ; Woda BA; Wilson JM; Robichaud N Cancer Res; 1990 Jan; 50(1):72-7. PubMed ID: 2293559 [TBL] [Abstract][Full Text] [Related]
9. DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions. Hanusovská E; Ujházy V Neoplasma; 1987; 34(6):721-6. PubMed ID: 3431611 [TBL] [Abstract][Full Text] [Related]
10. Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells. Micetich K; Zwelling LA; Kohn KW Cancer Res; 1983 Aug; 43(8):3609-13. PubMed ID: 6683124 [TBL] [Abstract][Full Text] [Related]
11. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Gibbons GR; Kaufmann WK; Chaney SG Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924 [TBL] [Abstract][Full Text] [Related]
12. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
13. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance. Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615 [TBL] [Abstract][Full Text] [Related]
14. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells. Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866 [TBL] [Abstract][Full Text] [Related]
15. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation. Jennerwein MM; Eastman A; Khokhar AR Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276 [TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells. Richon VM; Schulte N; Eastman A Cancer Res; 1987 Apr; 47(8):2056-61. PubMed ID: 3828995 [TBL] [Abstract][Full Text] [Related]
17. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts. Calsou P; Frit P; Salles B Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197 [TBL] [Abstract][Full Text] [Related]
18. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair. Chao CC Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407 [TBL] [Abstract][Full Text] [Related]
19. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II). Swinnen LJ; Fisher SG; Erickson LC Carcinogenesis; 1989 Aug; 10(8):1465-70. PubMed ID: 2752520 [TBL] [Abstract][Full Text] [Related]
20. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells. Chao CC Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]